logo
ProjectForthcoming

Transferable Trustworthy Radiotherapy with Artificial Intelligence

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Cancer is the leading cause of death in Europe and the second worldwide. Over 50% of patients are treated with Radiotherapy (RT) and it accounts for 40% of cures, yet recurrence and toxicities remain significant challenges. Despite major advances in imaging, planning and delivery, RT still largely follows a “one-dose-fits-all” approach, leading to variable outcomes, toxicities and limited adaptabi

Status
Prospective
Sector
Manufacturing (Industrial), Hospital, Education, Telecommunications
Location
France, Spain, United Kingdom, Switzerland, Germany, Italy, Greece
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Transferable Trustworthy Radiotherapy with Artificial Intelligence

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Transferable Trustworthy Radiotherapy with Artificial Intelligence” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in France, Spain, United Kingdom, Switzerland, Germany, Italy, Greece. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Cancer is the leading cause of death in Europe and the second worldwide. Over 50% of patients are treated with Radiotherapy (RT) and it accounts for 40% of cures, yet recurrence and toxicities remain significant challenges. Despite major advances in imaging, planning and delivery, RT still largely follows a “one-dose-fits-all” approach, leading to variable outcomes, toxicities and limited adaptability to patient-specific biology. Europe is currently undergoing a digital transformation driven by AI, advanced imaging and the European Health Data Space, but current AI solutions in RT remain fragmented, poorly generalizable and insufficiently explainable, preventing their safe deployment in clinical practice. TTRAIL aims at improving the safety, precision and personalization of radiotherapy (RT) by training 15 Doctoral Candidates as the first generation of Translational AI Radiotherapy Scientists, capable of uniting AI innovation with clinical radiotherapy, medical physics, regulatory science and digital-health translation. Their training will span multiscale data integration, uncertainty quantification, explainable and causal outcome modelling, digital twins and real-time adaptive dose delivery, aligned with the EU AI Act. The consortium unites top European universities, engineering schools, cancer centers and major industrial partners, providing access to cutting-edge RT platforms, large multicentre datasets and expertise across AI, imaging, oncology, physics and regulatory compliance. This intersectoral ecosystem ensures robust scientific training, clinical immersion, industrial exposure and strong open-science practices. By delivering a fully integrated, trust-by-design framework for AI-enabled Adaptive Radiotherapy, TTRAIL will produce highly skilled researchers able to lead the future of personalised, safe and explainable cancer treatment in Europe.

Location

Country

France, Spain, United Kingdom, Switzerland, Germany, Italy, Greece

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Hospital, Education, Telecommunications

Article published date

2026-10-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project